GlassScriptPhysician profile
Angela M Ravotti
NPI 1528638848
$3,520.96
in general payments reported to CMS, 2019-2025
31 companies · $1,166 in 2025
The $1,166 reported for 2025 was more than what 89% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $367 · 2022: $314 · 2023: $813 · 2024: $861 · 2025: $1,166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,840.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,840.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $965.28 | 2022-2025 | |
| Amgen INC. | $444.13 | 2021-2025 | Repatha, Repatha |
| Novo Nordisk INC | $328.55 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Heartflow, INC. | $287.52 | 2023-2025 | Ffrct |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $233.36 | 2024-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $207.19 | 2022-2024 | Xarelto |
| Impulse Dynamics (USA) INC. | $200.14 | 2023-2025 | Optimizer, Optimizer |
| Astrazeneca Pharmaceuticals LP | $114.91 | 2022-2025 | Farxiga, Wainua |
| Boehringer Ingelheim Pharmaceuticals, INC. | $103.39 | 2022-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $67.68 | 2021-2025 | |
| Lilly USA, LLC | $62.12 | 2021-2022 | |
| Boston Scientific Corporation | $55.74 | 2022-2024 | Watchman Flx |
| E.R. Squibb & Sons, L.L.C. | $48.23 | 2023 | Camzyos |
| Cvrx, INC. | $41.33 | 2023 | Barostim Neo System |
| Antares Pharma, INC. | $39.16 | 2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $32.96 | 2024 | Arcalyst |
| Teleflex LLC | $30.47 | 2025 | Chocolate |
| Abiomed | $29.91 | 2024 | Impella |
| Alexion Pharmaceuticals, INC. | $25.54 | 2021 | |
| Irhythm Technologies, INC. | $23.75 | 2024 | Zio Monitor, Zio Xt Patch |
| Corcept Therapeutics | $19.90 | 2021 | |
| Pfizer INC. | $19.81 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $18.88 | 2021 | |
| Scpharmaceuticals INC. | $18.20 | 2023 | |
| Mannkind Corporation | $18.19 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $16.74 | 2023 | Inpefa |
| Kiniksa Pharmaceuticals, LTD. | $16.11 | 2023 | Arcalyst |
| Xeris Pharmaceuticals, INC. | $16.08 | 2021 | |
| Ibsa Pharma INC. | $15.03 | 2021 | |
| Amarin Pharma, INC. | $13.29 | 2021 | |
| Shockwave Medical, INC | $7.37 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Ravotti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.